Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia
1 Tampilan
• 07/04/23
0
0
Menanamkan
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru